Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Drugmakers have poured small fortunes into the development of weight loss medicines in the past few years in attempts to lead ...

Cost is a major obstacle for many. The drugs can be expensive without insurance, with out-of-pocket expenses reaching ...

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a new study has ...

Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, ...

Weight loss injections are prescription medications to ... is in the glucagon-like peptide-1 receptor agonist (GLP-1) drug class approved for use in type 2 diabetes. A doctor may also prescribe ...

Novo Nordisk scored a much-needed win on Friday, with early-stage data on a new weight-loss drug that suggested it ... experimental Novo weight-loss shot called CagriSema fell far short of the ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...